Skip to main content
. 2020 May 9;9(5):1397. doi: 10.3390/jcm9051397

Figure 4.

Figure 4

Lipid and DNA oxidation products in patients with CGD as well as healthy controls. 8-OHdG, 8-hydroxy-D-guanosine; AOPP, advanced oxidation protein products; 4-HNE, 4-hydroxynonenal; 8-isoP, 8-isoprostanes; AGE, advanced glycation end products. Differences statistically significant at * p < 0.05.